glycoprotein iib/iiia

Lefradafiban（BIBU-104） 是一种口服血小板糖蛋白 IIb IIIa 受体拮抗剂，可用于研究心绞痛和急性冠状动脉综合症。

Tirofiban（MK383） hydrochloride monohydrate是一种非肽类糖蛋白IIb IIIa 的拮抗剂。

Gantofiban是一种糖蛋白 IIb IIIa（GP IIb IIIa）拮抗剂，可用于治疗心血管疾病，可用于研究血栓形成。

Roxifiban 是XV459的前药，是一种抗血小板剂，对血小板糖蛋白IIb IIIa 复合物(GPIIb IIIa)受体具有高亲和力和特异性。

Fradafiban binds to the human platelet GP IIb IIIa complex with a Kd value of 148 nM. Fradafiban is a non-polypeptide platelet glycoprotein IIb IIIa antagonist.

SR121566A is a novel non-peptide antagonist of Glycoprotein IIb IIIa (GP IIb-IIIa).

Tirofiban HCl is an antagonist of platelet glycoprotein-IIb IIIa receptor.

platelet fibrinogen receptor glycoprotein IIb IIIa (GpIIb IIIa) antagonist

DMP 728 is an antagonist of Glycoprotein IIb-IIIa.

Lamifiban is a nonpeptide glycoprotein IIb/IIIa antagonist. It prevents platelet loss during experimental cardiopulmonary bypass.

SKF 106760 is used as a glycoprotein IIb IIIa antagonist.

AR-H067637 is a rapid-binding, reversible and potent (inhibition constant K(i) = 2-4 nM), competitive inhibitor of thrombin, as well as of thrombin bound to fibrin (clot-bound thrombin) or to thrombomodulin. The total amount of free thrombin generated in

Batifiban, a glycoprotein IIb/IIIa antagonist, is used potentially for the treatment of coronary artery disease.

GPRP (Gly-Pro-Arg-Pro) 是一种纤维蛋白聚合抑制剂，能够抑制纤维蛋白原与血小板膜糖蛋白 Ⅱb IIIa 复合物(糖蛋白 IIb IIIa 受体)之间的相互作用。

Lotrafiban hydrochloride is an platelet glycoprotein IIb IIIa blocker with oral activity.

Sibrafiban (RO 48-3657) 是一种 Ro 44-3888 的口服非肽双前药，是一种选择性的糖蛋白 IIb IIIa 受体 (glycoprotein IIb IIIa receptor) 拮抗剂。Sibrafiban 能够抑制血小板聚集。

TAK 029 is a local glycoprotein IIb IIIa receptor inhibitor.

Eptifibatide (Eptifibatide Acetate) 是一种糖蛋白 IIb IIIa 抑制剂类的抗血小板药物，是一种由 6 个氨基酸和一个巯基丙酰基残基构成的环状七肽。

Eptifibatide acetate (148031-34-9 free base) (Eptifibatide acetate) 是一种糖蛋白 IIb IIIa 抑制剂类的抗血小板药物，是一种由 6 个氨基酸和一个巯基丙酰基残基构成的环状七肽。

Collagen-IN-1 (compound 3) is an ortho-carbonyl hydroquinone derivative exhibiting selective inhibition of collagen. It non-competitively inhibits agonist-induced platelet aggregation, with an IC50 value of 1.77 μM. Collagen-IN-1 effectively reduces the expression of P-selectin, activation of glycoprotein IIb IIIa, and release of adenosine triphosphate and CD63 from platelets. This compound holds promise for research into platelet-related thrombosis diseases [1].

Lotrafiban 是一种口服具有活力的血小板膜糖蛋白 IIb IIIa 阻滞剂，能够用于治疗冠心病和脑血管疾病的治疗。

L-739758 is a glycoprotein IIb IIIa inhibitor.

Fradafiban (BIBU-52) hydrochloride 是一种非肽血小板糖蛋白 IIb IIIa 复合体拮抗剂，其与人血小板 GP IIb IIIa 复合体结合，Kd 值为 148 nM。

Abciximab (C7E3) 是一种小鼠 人嵌合单克隆抗体，是一种有效的糖蛋白 IIb IIIa (glycoprotein IIb IIIa) 抑制剂。 Abciximab 具有抗血小板聚集和白细胞粘附的作用，通过与糖蛋白 IIb IIIa、vitronectin 和 Mac-1 受体结合发挥作用。